Venlafaxine Hydrochloride Tablet, Extended Release
Product Images NDC 69367-417

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 69367-417). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Venlafaxine 01)

FDA Label Image

Principal Display Panel (150 mg Tablet Bottle Label)

This text provides information on the usual dosage and storage instructions for venlafaxine hydrochloride extended-release tablets. It mentions that the tablets contain 150 mg of venlafaxine hydrochloride. It also advises not to crush, chew, or split the tablets and emphasizes protecting them from moisture and humidity. Additionally, it indicates the need to dispense accompanying medication guides for each patient. The manufacturer is identified as Westminster Pharmaceuticals, LLC.*

FDA Label Image

Principal Display Panel (225 mg Tablet Bottle Label)

This text provides information about a medication called Venlafaxine Hydrochloride Extended-release Tablets, with a strength equivalent to 225 mg. It includes instructions to store the medication at 25°C, with temperature excursions permitted in a defined range. The manufacturer is Westminster Pharmaceuticals, LLC, with additional information about dispensing and precautions related to moisture and humidity. It also mentions the requirement of dispensing the medication guide to each patient and using a child-resistant closure for the container.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.